<DOC>
	<DOC>NCT00330876</DOC>
	<brief_summary>This is an open-label extension study of NK-104-306 (NCT00257686) for elderly patients with hypercholesterolemia or combined dyslipidemia.</brief_summary>
	<brief_title>Study of Pitavastatin in Elderly Patients With Primary Hypercholesterolemia or Combined Dyslipidemia</brief_title>
	<detailed_description>This was an open-label study of 60 weeks duration in elderly patients (â‰¥65 years) with primary hypercholesterolemia or combined dyslipidemia who completed the 12 week treatment in study NK-104-306 and who met the inclusion/exclusion criteria. Patients who qualified started open-label treatment with pitavastatin 2 mg QD. The dose of pitavastatin could be increased to 4 mg QD after at least 8 weeks of treatment at 2 mg QD, in patients who failed to attain their LDL-C target.</detailed_description>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Pitavastatin</mesh_term>
	<criteria>Greater than or equal to 65 years of age Primary hypercholesterolemia Combined dyslipidemia Completed study NK104306 (NCT00257686) Failed to complete study NK104306(NCT00257686)</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>pitavastatin</keyword>
	<keyword>hypercholesterolemia</keyword>
	<keyword>combined dyslipidemia</keyword>
</DOC>